moxisylyte has been researched along with Central Hypothyroidism in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Valcavi, R | 1 |
| Dieguez, C | 1 |
| Azzarito, C | 1 |
| Artioli, C | 1 |
| Portioli, I | 1 |
| Scanlon, MF | 1 |
1 other study available for moxisylyte and Central Hypothyroidism
| Article | Year |
|---|---|
Alpha-adrenoreceptor blockade with thymoxamine reduces basal thyrotrophin levels but does not influence circadian thyrotrophin changes in man.
Topics: Adult; Circadian Rhythm; Female; Humans; Hypothyroidism; Middle Aged; Moxisylyte; Prolactin; Thyrotr | 1987 |